Immunocompetent Patient Co-Infected with COVID-19 and Non-HIV Severe Pneumocystis jirovecii Pneumonia

IF 7.2 2区医学 Q1 IMMUNOLOGY

Emerging Infectious Diseases Pub Date : 2024-08-15 DOI:10.3201/eid3009.240615

Songsong Yu, Tiecheng Yang

引用次数: 0

Abstract

Pneumocystis jirovecii pneumonia is an opportunistic infection that affects HIV-infected and immunocompromised persons and rarely affects immunocompetent patients. However, after the advent of the COVID-19 pandemic, some COVID-19 patients without immunocompromise or HIV were infected with P. jirovecii. Clinical manifestations were atypical, easily misdiagnosed, and rapidly progressive, and the prognosis was poor.

查看原文本刊更多论文

合并感染 COVID-19 和非艾滋病毒严重肺孢子虫肺炎的免疫功能正常患者

吉罗韦氏肺孢子菌肺炎是一种机会性感染，感染者多为艾滋病毒感染者和免疫力低下者，免疫力正常的患者很少感染。然而，在 COVID-19 大流行之后，一些没有免疫力低下或感染艾滋病毒的 COVID-19 患者感染了焦韦氏肺孢子菌。临床表现不典型，容易误诊，病情进展迅速，预后不良。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Emerging Infectious Diseases 医学-传染病学

CiteScore

17.30

自引率

1.70%

发文量

505

审稿时长

1 months

期刊介绍： Emerging Infectious Diseases is a monthly open access journal published by the Centers for Disease Control and Prevention. The primary goal of this peer-reviewed journal is to advance the global recognition of both new and reemerging infectious diseases, while also enhancing our understanding of the underlying factors that contribute to disease emergence, prevention, and elimination. Targeted towards professionals in the field of infectious diseases and related sciences, the journal encourages diverse contributions from experts in academic research, industry, clinical practice, public health, as well as specialists in economics, social sciences, and other relevant disciplines. By fostering a collaborative approach, Emerging Infectious Diseases aims to facilitate interdisciplinary dialogue and address the multifaceted challenges posed by infectious diseases.